Without hijacking the BOT thread and turning into a PAA thread, the timeline for PAA to complete their studies is likely less than 12 months. Have a read up on the phase2/3 trial info, very encouraging and only need $30m to complete them and aiming to have the drug on the market in <18 months.
Your point about sticking to a strategy is a sound one.
GLTA
MTC
Bot Chart, page-11583
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
33.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $519.7M | |||
| Open | High | Low | Value | Volume |
| 34.5¢ | 35.5¢ | 33.0¢ | $4.907M | 14.27M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 33 | 592847 | 33.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.0¢ | 307941 | 5 |
View Market Depth
| Last trade - 16.10pm 17/06/2024 (20 minute delay) ? |
|
|||||
|
Last
33.5¢ |
Change
0.000 ( 2.35 %) |
||||
| Open | High | Low | Volume | ||
| 34.5¢ | 35.3¢ | 33.3¢ | 7383812 | ||
| Last updated 15.59pm 17/06/2024 ? | |||||
| BOT (ASX) Chart |
